Cargando…
Shortcomings in Pharmacy Benefit Forecasting - Interferon Beta Products
Autor principal: | Rich, Sheldon |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Academy of Managed Care Pharmacy
2003
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10437280/ https://www.ncbi.nlm.nih.gov/pubmed/14613461 http://dx.doi.org/10.18553/jmcp.2003.9.4.373 |
Ejemplares similares
-
Evolution, Benefits, and Shortcomings of Vaccine Management
por: McCullers, Jonathan A.
Publicado: (2007) -
Shortcomings in addressing attacks on health care
por: Jaff, Dilshad
Publicado: (2018) -
Hemicrania continua: major shortcomings in the new classification
por: Fredriksen, Torbjørn A, et al.
Publicado: (2014) -
Pharmacy Benefit Forecast for a New Interferon Beta-1a for the Treatment of Multiple Sclerosis: Development of a First-Line Decision Tool for Pharmacy-Budget Planning Using Administrative Claims Data
por: Meryer, Christina
Publicado: (2003) -
Non-Standardized Terminology in Healthcare: Shortcomings and Subsequent Rectifications [Letter]
por: Kumar, Harit, et al.
Publicado: (2022)